CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and prima...
Phase 3
Saint Louis, Missouri, United States and 22 other locations
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
Saint Louis, Missouri, United States and 46 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Saint Louis, Missouri, United States and 21 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Saint Louis, Missouri, United States and 176 other locations
positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...
Phase 2
Saint Louis, Missouri, United States and 70 other locations
This is a Phase 1b open-label, multicenter study, evaluating the safety, tolerability, preliminary clinical activity, pharmacokinetics (PK), and phar...
Phase 1
Saint Louis, Missouri, United States and 21 other locations
of Mirvetuximab Soravtansine in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with hig...
Phase 2
Saint Louis, Missouri, United States and 77 other locations
This is a randomized, open label, multicenter trial to evaluate the safety, dosing, efficacy and biological activity of intraperitoneal IMNN-001 plus...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 20 other locations
The primary objective is to evaluate in participants with high-grade serous ovarian cancer (HGSOC), whether the reduction from base...
Phase 2
Saint Louis, Missouri, United States and 44 other locations
ecteribulin (MORAb-202) and compare it to Investigator's choice (IC) chemotherapy in female participants with platinum-resistant HGS ovarian....
Phase 2
Saint Louis, Missouri, United States and 82 other locations
Clinical trials
Research sites
Resources
Legal